Recombinant spider silk

Search documents
Kraig Biocraft Laboratories Successfully Completes Lab-to-Field Transition for Three New Spider Silk Production Strains
Globenewswire· 2025-07-21 11:05
Newly Deployed Strains Deliver Strong Performance in Initial Field Rearing Cycles, Paving the Way for Accelerated Deployment of Next-Generation TransgenicsANN ARBOR, Mich., July 21, 2025 (GLOBE NEWSWIRE) -- Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, announces the successful completion of the first rearing cycles for its three newest recombinant spider silk production strains. These newly developed strains were transitioned from the ...
Kraig Biocraft Laboratories Receives Business License to Begin Operations in Cambodia
Globenewswire· 2025-05-15 11:05
Core Insights - Kraig Biocraft Laboratories, Inc. has received a business license to operate in Cambodia, marking a significant step in its strategy to scale up and diversify production capabilities in response to its 2025 expansion initiatives [1][2][3] Group 1: Expansion Strategy - The decision to launch operations in Cambodia is based on the positive momentum achieved through expanded production efforts this year [2] - The Cambodian business license is expected to support the company's goals of increasing production capacity while diversifying its production footprint [3] Group 2: Production and Technology - The new location in Cambodia is seen as an opportunity to enhance the company's spider silk production scale, leveraging the right combination of climate and infrastructure [3] - Kraig Labs continues to invest in research and infrastructure to advance the performance and scalability of its proprietary recombinant spider silk technologies [3][4] Group 3: Industry Position - Kraig Labs is recognized as a leader in genetically engineered spider silk-based fiber technologies, with significant breakthroughs that have implications for the global textile industry [5][6]